The Impact of a Nationwide Introduction of New Drugs and a Treatment Protocol for Glaucoma on the Number of Glaucoma Surgeries-Reference-Cited by-同舟云学术

The Impact of a Nationwide Introduction of New Drugs and a Treatment Protocol for Glaucoma on the Number of Glaucoma Surgeries

Published:2005-06 Issue:3 Volume:14 Page:239-242
ISSN:1057-0829
Container-title:Journal of Glaucoma
language:en
Short-container-title:Journal of Glaucoma

Author:

Valk Rikkert van der,Schouten Jan S.A.G,Webers Carroll A.B,Beckers Henny J.M,Amelsvoort Ludovic G.P.M. van,Schouten Hubert J.A,Hendrikse Fred,Prins Martin H

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology

Reference26 articles.

1. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP

2. A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure

3. Latanoprost

4. Acetazolamide and Aplastic Anemia

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nationwide Analysis of Glaucoma Surgeries in Fiscal Years of 2014 and 2020 in Japan;Journal of Personalized Medicine;2023-06-26

2. Changing Trends in Glaucoma Surgery Over the Past 5 Years in China;Journal of Glaucoma;2022-02-28

3. Association between Early Anatomic Response and Intraocular Pressure Change after Intravitreal Dexamethasone Implant: An Optical Coherence Tomography Study;Journal of Clinical Medicine;2020-08-20

4. Prescribing Trends of Topical Glaucoma Medications in Australia From 2001 to 2017;Journal of Glaucoma;2019-11-26

Comparison of clinical effects of two latanoprost 0.005% solutions (Xalatan^® and Arulatan^®) in primary open-angle glaucoma or ocular hypertensive patients: a randomized clinical trial

;Clinical Ophthalmology;2019-04